Application of constrained aza-valine analogs for Smac mimicry.

Biopolymers

Département De Chimie, Université De Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, H3C 3J7, Canada.

Published: May 2016

Constrained azapeptides were designed based on the Ala-Val-Pro-Ile sequence from the second mitochondria-derived activator of caspases (Smac) protein and tested for ability to induce apoptosis in cancer cells. Diels-Alder cyclizations and Alder-ene reactions on azopeptides enabled construction of a set of constrained aza-valine dipeptide building blocks, that were introduced into mimics using effective coupling conditions to acylate bulky semicarbazide residues. Evaluation of azapeptides 7-11 in MCF-7 breast cancer cells indicated aza-cyclohexanylglycyine analog 11 induced cell death more efficiently than the parent tetrapeptide likely by a caspase-9 mediated apoptotic pathway. © 2016 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 235-244, 2016.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bip.22851DOI Listing

Publication Analysis

Top Keywords

constrained aza-valine
8
cancer cells
8
application constrained
4
aza-valine analogs
4
analogs smac
4
smac mimicry
4
mimicry constrained
4
constrained azapeptides
4
azapeptides designed
4
designed based
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!